Xeraya closes investment into Vittamed Corporation
October 16, 2015
Vittamed ("Company") has become Xeraya's second investment that is structured based on Shariah-compliant principles. The Mudharabah Innovation Fund (managed by Xeraya for the Ministry of Finance) will be a co-investor in Vittamed once the Company has achieved certain Malaysian-centricity milestones.
Vittamed is a neurodiagnostics medical device company that has developed non-invasive ultrasound-based devices to measure intracranial pressure (“ICP”) and monitor cerebral blood flow autoregulation ("CA"), where current standard of care requires invasive methods. The primary focus of the devices is to closely measure and monitor critical care patients suffering from neurological diseases, post-stroke complications or traumatic brain injuries. The Company has received the CE mark for both its devices.
More information can be found here: http://www.prnewswire.com/news-releases/
Back to News & Events